Albert David (ALBERTDAVD)₹800.90+0.89%Pharmaceuticals
In the Jun 2026 quarter (standalone), Albert David reported sales of ₹101 Cr, up 42.3% from Jun 2025, and net profit of ₹32.01 Cr, up 300.6% year on year. For the year to Mar 2026, sales were ₹333 Cr and net profit −₹0.99 Cr.
Company filings, standalone accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 93.21 | 88.21 | 89.19 | 89.13 | 98.21 | 83.09 | 75.17 | 71.15 | 87.22 | 90.21 | 86.13 | 101 |
| Expenses | 77.35 | 80.34 | 79.35 | 88.40 | 92.32 | 82.30 | 80.32 | 81.31 | 85.39 | 79.32 | 83.30 | 91.39 |
| Operating Profit | 16.03 | 8.01 | 10.01 | 1.01 | 6.01 | 1.01 | −5.01 | −11.02 | 3.01 | 11.01 | 3.01 | 11.02 |
| OPM % | 17.0% | 9.0% | 11.0% | 1.0% | 6.0% | 0.8% | −6.0% | −15.1% | 2.9% | 12.0% | 3.2% | 10.0% |
| Other Income | 12.04 | 17.07 | 10.03 | 23.09 | 21.08 | −9.03 | −5.02 | 22.08 | −2.01 | 12.04 | −25.09 | 28.11 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 1.01 | 1.01 | 0.00 | 1.01 |
| Depreciation | 1.01 | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 | 3.01 | 2.01 |
| Profit before tax | 26.96 | 22.97 | 17.98 | 21.95 | 24.96 | −9.98 | −11.97 | 7.98 | −2.99 | 19.97 | −24.94 | 35.95 |
| Tax % | 24.0% | 19.9% | 29.0% | 14.9% | 27.9% | −8.1% | −13.0% | 6.0% | 27.9% | 22.9% | −15.1% | 11.0% |
| Net Profit | 19.98 | 19.01 | 12.99 | 18.99 | 17.99 | −8.99 | −9.99 | 7.99 | −2.99 | 15.01 | −20.99 | 32.01 |
| EPS (Rs) | 35.55 | 32.75 | 22.61 | 33.00 | 31.65 | −16.43 | −18.08 | 13.90 | −5.77 | 26.80 | −37.50 | 56.06 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 318 | 293 | 286 | 317 | 321 | 246 | 314 | 342 | 363 | 346 | 333 | 365 |
| Expenses | 287 | 267 | 268 | 287 | 290 | 228 | 273 | 298 | 316 | 343 | 328 | 339 |
| Operating Profit | 31.05 | 27.03 | 18.01 | 30.05 | 30.04 | 19.03 | 41.05 | 44.06 | 47.05 | 3.01 | 6.01 | 28.05 |
| OPM % | 10.0% | 9.0% | 6.0% | 10.0% | 10.0% | 8.0% | 13.0% | 13.0% | 13.0% | 0.9% | 1.7% | 7.7% |
| Other Income | 43.13 | 8.03 | 9.03 | 15.06 | 7.02 | 17.06 | 16.06 | 15.04 | 58.18 | 30.09 | 7.02 | 13.05 |
| Interest | 2.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 0.00 | 1.01 | 3.01 | 3.03 |
| Depreciation | 9.01 | 8.01 | 8.01 | 7.01 | 8.01 | 8.02 | 9.01 | 9.02 | 7.01 | 7.01 | 10.01 | 9.04 |
| Profit before tax | 62.86 | 25.96 | 17.96 | 37.96 | 28.95 | 26.98 | 46.90 | 50.94 | 96.91 | 24.95 | 0.99 | 27.99 |
| Tax % | 23.9% | 38.9% | 44.9% | 29.0% | 33.9% | 18.9% | 25.0% | 28.9% | 22.0% | 32.0% | 378.9% | — |
| Exceptional items | 33.96 | 0.00 | 1.99 | 0.00 | 0.00 | 0.99 | 1.99 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 47.96 | 15.99 | 9.99 | 27.01 | 18.99 | 21.99 | 35.01 | 36.02 | 74.96 | 16.99 | −0.99 | 23.04 |
| EPS (Rs) | 84.09 | 27.92 | 17.23 | 46.67 | 33.54 | 38.74 | 61.73 | 63.29 | 132.10 | 30.11 | −2.60 | 39.59 |
| Dividend payout % | 7.0% | 20.1% | 32.1% | 13.1% | 21.1% | 15.1% | 15.1% | 14.1% | 9.1% | 17.1% | −191.9% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.99 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.01 | 6.01 | 6.01 | 6.01 | 6.01 |
| Reserves | 86.84 | 131 | 177 | 180 | 205 | 217 | 239 | 274 | 306 | 377 | 388 | 386 |
| Borrowings | 29.98 | 20.02 | 30.03 | 28.04 | 0.00 | 2.01 | 2.01 | 6.03 | 5.02 | 3.01 | 12.03 | 30.08 |
| Other Liabilities | 70.66 | 66.67 | 70.65 | 75.64 | 83.60 | 94.55 | 94.55 | 115 | 106 | 111 | 106 | 97.52 |
| Total Liabilities | 192 | 224 | 285 | 290 | 295 | 320 | 341 | 401 | 423 | 498 | 511 | 519 |
| Fixed Assets | 48.86 | 43.86 | 86.75 | 82.77 | 76.77 | 90.74 | 83.78 | 87.71 | 79.78 | 82.71 | 98.63 | 99.72 |
| CWIP | 5.01 | 4.99 | 9.01 | 5.01 | 5.01 | 2.01 | 1.01 | 0.99 | 3.01 | 6.99 | 2.01 | 21.02 |
| Investments | 16.06 | 48.10 | 59.15 | 68.24 | 113 | 122 | 138 | 184 | 194 | 274 | 261 | 244 |
| Other Assets | 122 | 127 | 130 | 134 | 98.67 | 106 | 119 | 130 | 148 | 135 | 150 | 154 |
| Inventories | 52.09 | 49.05 | 51.02 | 43.01 | 44.06 | 43.04 | 36.02 | 39.02 | 51.03 | 44.03 | 64.02 | 58.03 |
| Trade receivables | 40.82 | 34.88 | 32.87 | 26.89 | 21.93 | 29.89 | 18.92 | 24.91 | 29.88 | 28.89 | 26.91 | 33.89 |
| Cash & equivalents | 9.98 | 22.94 | 14.98 | 25.95 | 6.99 | 6.98 | 34.93 | 18.97 | 24.97 | 30.91 | 1.99 | 32.95 |
| Total Assets | 192 | 224 | 285 | 290 | 295 | 320 | 341 | 401 | 423 | 498 | 511 | 519 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 28.01 | 68.01 | 20.01 | 30.04 | 32.01 | 30.01 | 37.03 | 40.05 | 11.02 | 46.01 | −28.03 | −8.01 |
| Cash from investing activity | −9.01 | −38.07 | −36.04 | −11.02 | −19.03 | −20.03 | −37.09 | −40.09 | −5.01 | −33.04 | 23.04 | −4.01 |
| Cash from financing activity | −17.98 | −17.96 | 6.99 | −4.99 | −16.96 | −9.99 | −1.99 | −1.99 | −5.99 | −7.99 | 0.00 | 11.98 |
| Net cash flow | 0.99 | 11.98 | −9.99 | 14.99 | −3.99 | 0.00 | −1.99 | −0.99 | −0.99 | 3.99 | −4.99 | 0.00 |
| Capex | 9.71 | 5.75 | 20.09 | 3.78 | 1.97 | 15.44 | 1.64 | 11.10 | 5.25 | 10.89 | 14.88 | 29.14 |
| Free cash flow | 17.96 | 61.94 | 0.00 | 30.93 | 44.95 | 14.97 | 34.95 | 31.95 | 5.99 | 34.93 | −42.90 | −35.96 |
| CFO / OP % | 95.1% | 303.1% | 115.1% | 204.1% | 126.1% | 149.0% | 202.1% | 129.1% | 59.1% | 131.1% | −628.9% | −47.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 46 | 40 | 40 | 34 | 24 | 33 | 28 | 28 | 31 | 29 | 28 | 36 |
| Inventory days | 175 | 186 | 216 | 172 | 150 | 147 | 150 | 123 | 148 | 125 | 200 | 186 |
| Days payable | 103 | 102 | 117 | 127 | 102 | 132 | 104 | 96 | 95 | 98 | 118 | 104 |
| Cash conversion cycle | 121 | 127 | 142 | 82 | 75 | 51 | 77 | 58 | 88 | 59 | 113 | 121 |
| Working capital days | 28 | 26 | 25 | 11 | 22 | 19 | −9 | −33 | 15 | −12 | 7 | 2 |
| ROCE % | 18.1% | 17.1% | 15.1% | 7.1% | 18.1% | 14.0% | 12.1% | 17.1% | 17.0% | 28.1% | 6.0% | 1.0% |
For the Jun 2026 quarter, Albert David reported sales of ₹101 Cr, up 42.3% year on year and net profit of ₹32.01 Cr, up 300.6% year on year. The operating margin was 10.0%.
Albert David's sales for the year to Mar 2026 were ₹333 Cr; over the last twelve months they were ₹365 Cr.
Net profit for the year to Mar 2026 was −₹0.99 Cr, and ₹23.04 Cr over the last twelve months. Earnings per share over the same trailing period were ₹39.59.
Albert David reported borrowings of ₹30.08 Cr at Mar 2026, against cash and equivalents of ₹32.95 Cr.
Cash from operations was −₹8.01 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹35.96 Cr.